Role for nerve growth factor in the in vivo regulation of glutathione in response to LPS in mice by Arsenijevic, Denis et al.
Role for nerve growth factor in the in vivo regulation
of glutathione in response to LPS in mice
Denis Arsenijevic1, Noemi Hernadfalvi1, Claudia von Meyenburg1, Brigitte Onteniente2,
Denis Richard3, Wolfgang Langhans1
1 Institute of Animal Sciences, ETH Zurich, Schwerzenbach, Switzerland
2 ISERM UMR421, Creteil, France
3 Department of Anatomy and Physiology, Laval University, Quebec, Canada
Correspondence : Corresponding author’s current address: Division of Physiology, Department of Medicine, University of Fribourg, Fribourg,
Switzerland
<denis.arsenijevic@unifr.ch>
ABSTRACT. Because the redox state regulator glutathione (GSH), which inﬂuences lipopolysaccharide (LPS)
anorexia, may be controlled by cytokines, we studied the roles of tumour necrosis factor-alpha (TNFa) and nerve
growth factor (NGF) in the GSH response to intraperitoneal (ip) LPS injection in mice. Basal NGF and total
reduced GSH (trGSH) levels were up-regulated in brain and liver of TNFa-knock-out (KO) mice, and this was
associated with attenuated LPS anorexia. The increases in NGF and trGSH presumably contributed to the
attenuated anorexia in response to LPS because transgenic mice over-expressing NGF (NGF-tg mice) also had
increased trGSH levels and displayed attenuated anorexia compared to the corresponding wild type (WT) mice.
Attenuated LPS anorexia in NGF-tg mice was accompanied by reduced serum TNFa and IFNc levels compared
to WT mice. In response to a second injection of LPS, NGF and trGSH levels, but not TNFa levels changed. This
suggests that in vivo tissue trGSH changes following LPS in LPS-naïve or LPS-pretreated mice are regulated by
NGF rather than TNFa. The ﬁnding that genetic TNFa deﬁciency did not inhibit the acute trGSH response to LPS
supports this interpretation. In sum, the results indicate i) that a decrease or increase in NGF is accompanied by
a decrease or increase in trGSH levels and ii) that elevated NGF and/or trGSH levels attenuate some of the
responses to LPS such as anorexia and cytokine production.
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Pro-inﬂammatory cytokines are common mediators of
oxidative stress [1], which is one important pathological
mechanism of tissue dysfunction. Antioxidants have been
shown to modify the inﬂammatory process by attenuating
cytokine production and reducing oxidative stress [2]. In
turn, cytokine signalling can be modiﬁed by antioxidants
such as glutathione (GSH) [3, 4]. GSH is produced mainly
in the liver and is taken up from the circulation by other
tissues [5]. GSH has been implicated in limiting LPS-
induced pathology [6]. One of the cytokines that suppos-
edly enhances oxidative stress in response to LPS and
other immune challenges is tumour necrosis factor-alpha
(TNFa). Yet, although some studies implicate TNFa in
reactive oxygen species toxicity [1], other ﬁndings sug-
gested it has protective effects [7-9]. One possible expla-
nation for these discrepancies is that there may be a tissue-
speciﬁc, local cytokine and/or redox state regulation.
Thus, we have seen tissue-speciﬁc redox regulation in a
murine Toxoplasma gondii infection model, in which oxi-
dative stress was reduced in the brain and markedly in-
creased in the liver at the same time [10]. Circulating
hormones may also play an important role in tissue redox
regulation. It has been shown that growth hormone (GH)
and leptin not only inﬂuence cytokine production, but also
GSH levels [11, 12]. Furthermore, both hormones may
regulate nerve growth factor (NGF), which is an important
activator of antioxidant mechanisms [13-16]. Based on
results from in vitro studies [17], NGF may be particularly
important in regulating GSH. Recently, TNFa has been
implicated in the control of NGF [18], suggesting that
there are complex interactions between these two cytok-
ines and GSH. Therefore, the aim of the present study was
to examine the roles of TNFa and NGF in the in vivo
regulation of GSH in response to LPS in 1) LPS-naïve and
2) LPS-pretreated mice.
METHODS
Mice, housing and diets
We used male, 8-16 week-old 25-30 g (body weight)
knockout (KO) or transgenic (tg) and corresponding wild
type mice for all experiments. Tumour necrosis factor-
alpha-knockout (TNFa-KO) mice on a c57/bl6 back-
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ground [19], and corresponding wild-type (WT) mice were
obtained from Dr. I. Garcia (University of Geneva,
Switzerland). Nerve growth factor-over-expressing trans-
genic mice (NGF-tg) and corresponding WT mice on a bl6
background were obtained from Dr. B. Onteniente
(INSERM UMR 421, Creteil, France) [20]. Mice were
housed individually in stainless steel cages with a grid
ﬂoor and kept on a 12:12 hour light:dark cycle. Drug
solutions were freshly prepared and always injected
1-2 hours before the onset of the dark cycle. Mice had
continuous ad libitum access to water and powdered labo-
ratory chow (Nafag, Gossau, Switzerland). Food intake
after lipopolysaccharide (LPS) injections (see below) was
measured (± 0.1 g) at various time intervals (6, 12 and
24 hours) by subtracting the weight of the container with
the food and taking into account any spillage. All proce-
dures were approved by the Canton of Zurich Veterinary
Ofﬁce.
Role of TNFa in LPS-induced changes in i) NGF
and GSH levels in brain and liver and ii) serum levels
of growth hormone and leptin
We used 16 TNFa-KO and 16 corresponding WT mice to
examine whether the lack of TNFa changes NGF and total
reduced GSH (trGSH) levels in brain and liver under
baseline conditions or after intraperitoneal (ip) injection of
LPS (4 lg/mouse). The LPS dose was chosen because it
was the lowest dose which caused a reliable food intake
reduction for 24 hours in a preliminary experiment in WT
mice with 0, 0.4, 4 and 40 lg per 25 g body weight (n
= 8/dose). In addition to NGF and trGSH, TNFa was
measured in brain and liver of WT mice. WT and
TNFa-KO mice were injected with LPS (12 WT and 12
TNFa-KO) or saline (n = 4 of each genotype). Mice were
sacriﬁced immediately after saline injection (time point 0,
baseline) or at 15, 90 and 240 minutes (n = 4/genotype and
time point) after LPS injection. Serum, brain and liver
were collected and tissue levels of NGF, trGSH, and TNFa
were determined as described below. Growth hormone was
determined using rat growth hormone immunoassay from
Amersham (Otelﬁngen, Switzerland) and leptin was deter-
mined by mouse immunoassay kit from Crystal Chem
(Chicago, USA).
Role of NGF in LPS-induced changes in i) GSH levels
in brain, liver and plasma and ii) in LPS-induced
anorexia
Four NGF-tg and four corresponding WT mice were used
per group. Blood was collected in EDTA-tubes by heart
puncture. Immediately thereafter, mice were sacriﬁced by
CO2 and brain and liver were removed, frozen in liquid
nitrogen, and stored at –80°C. Furthermore, to determine
whether NGF-tg mice had an altered anorexic response to
LPS, 12 NGF-tg and 12 WT mice were injected (ip) with
LPS (n = 6/genotype) or saline (n = 6/genotype) and food
intake measured at 24h after injection. Serum, brain and
liver were collected, snap frozen in liquid nitrogen, and
stored at -80C° until analysis. Throughout the extraction
procedure for GSH and cytokines, samples were kept on
ice. Tissues were homogenized with phosphate-buffered
saline (600 ll/100 mg tissue) using a polytron PT1200
homogenizer (Kinematica, Lucern, Switzerland). The so-
lution underwent a precipitation reaction with phosphate
solution (glacial metaphosphoric acid 1.67 g, disodium
EDTA 0.2 g, NaCl 30 g, in 100 ml distilled water). This
solution was centrifuged, the supernatant was collected,
and phosphate buffer (0.3M Na2HPO4) added. From this,
an aliquot was taken and the trGSH tissue levels were
measured using a method based on the formation of a
chromophoric product resulting from the reaction with
0.04% 5,5’-dithiobis-2-nitrobenzoic acid (D8130, DTNB,
Sigma Chemicals, St. Louis, MO, USA) and GSH (G4251,
Sigma, Buchs, Switzerland) [21].
Effect of anorexia on brain and liver GSH levels
As the level of food intake can alter tissue GSH, we
examined whether LPS-induced changes in trGSH in brain
and liver could be due to the decrease in food intake after
LPS. Additional groups of NGF-tg and WT mice were
underfed (NGF-tguf and WTuf, n = 4, each) to the same
level as NGFtg and WT mice that received LPS. An iden-
tical experiment was performed in TNFa-KO and corre-
sponding WT mice (TNFa-KOuf and WTuf).
Role of TNFa and NGF in LPS tolerance
To investigate whether the lack of TNFa changes the
evolution of NGF levels during induction of tolerance to
LPS, we injected TNFa-KO and corresponding WT mice
with 4lg LPS twice, on day 1 of the experiment and on day
4 (see table 1), when the animals’ food intake had returned
to pre-injection values. As circulating TNFa usually peaks
at approximately 90 minutes after LPS injection, we com-
pared plasma TNFa and NGF levels at this time point after
LPS or saline injection in LPS-naïve and LPS-pretreated
TNFa-KO and WT mice to see whether LPS pretreatment
affected LPS-induced changes in plasma NGF and TNFa
(in WT mice). Four mice for each subgroup of WT and
TNFa-KO mice were used according to table 1. Blood was
collected by heart puncture. Serum was frozen and stored
at -80°C [24],, and TNFa and NGF were measured using
immunoassay kits from Amersham (Otelﬁngen, Switzer-
land) and Catalys (Wallisellen, Switzerland), respectively.
Statistics
Differences between groups were determined by using
Kruskal-Wallis test with a Dunn post hoc test. A value of
p<0.05 was considered signiﬁcant. Non-parametrical
Spearman correlation coefﬁcients were calculated using
the Instat program (GraphPad Incorporation, San Diego,
CA, USA).
RESULTS
Role of TNFa in LPS-induced changes in i) NGF
and GSH levels in brain and liver and ii) serum levels
of growth hormone and leptin
TNFa-KO mice had higher baseline trGSH levels than WT
mice in brain (p<0.05) (ﬁgure 1A) and liver (p < 0.001)
(ﬁgure 1B). LPS reduced trGSH in brain and liver at 15
minutes in TNFa-KO and WT mice and at 90 minutes in
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TNFa-KO mice. At 240 minutes after LPS injection, brain
and liver GSH had returned to baseline levels in mice of
both genotypes. LPS progressively increased brain TNFa
in WT mice at 15, 90 and 240 minutes (ﬁgure 1C). Also,
LPS increased TNFa at 15 and 90 minutes after injection,
in livers of WT mice (ﬁgure 1D). No TNFa was detected in
brains and livers of TNFa-KO mice at any of the time
points (ﬁgure 1C and 1D). TNFa-KO mice had higher
basal NGF levels than WT mice in brain (p < 0.001)
(ﬁgure 1E) and liver (p < 0.001) (ﬁgure 1F). LPS reduced
brain and liver NGF levels at 15 and 90 minutes after
injection in both TNFa-KO and WT mice. At 240 minutes
after LPS injection, brain and liver NGF levels had in-
creased again, but brain NGF was still lower than baseline
in TNFa-KO mice (ﬁgure 1E). Hepatic NGF and trGSH
levels after LPS treatment were correlated in TNFa-KO
(Spearman correlation coefﬁcient: 0.91) and WT mice
(0.89). TNFa deﬁciency did not result in differences in
basal growth hormone levels, and no differences where
seen in the response to LPS throughout the measurement
period (ﬁgure 2A). Also, basal serum levels of leptin did
not differ between WT and TNFa-KO mice, but serum
leptin was decreased (p < 0.001) at 15 minutes after LPS
injection in WT mice. This decrease did not reach signiﬁ-
cance in the TNFa-KO mice (ﬁgure 2B). Thereafter, serum
leptin returned to basal levels in WT mice and was in-
creased in TNFa-KO mice at 240 minutes after LPS injec-
tion, compared to basal levels (p < 0.01) and compared to
WT leptin levels at this time point (p < 0.01) (ﬁgure 2B).
Role of NGF in LPS-induced changes in i) GSH levels
in brain, liver and plasma and ii) in LPS-induced
anorexia
Baseline trGSH levels in brain, liver and plasma were
higher (all p < 0.001) in NGF-tg than in WT mice (ﬁgure
3A). Baseline food intake did not differ between WT and
NGF-tg mice (ﬁgure 3B). LPS decreased 24-hour food
intake in both, WT and NGF-tg mice, but the LPS-induced
anorexia was less pronounced, and of shorter duration in
NGF-tg mice than in WT mice (p < 0.001) (ﬁgure 3B).
NGF-tg mice had higher serum levels of NGF, but lower
serum levels of TNFa and IFNc 240 minutes after LPS
injection (p < 0.001 p < 0.01 and p < 0.001 for NGF,
TNFa, and IFNc, respectively) than WT mice.
Effect of anorexia on brain and liver GSH levels
Underfeeding (uf) did not cause signiﬁcant changes in
brain trGSH compared to ad libitum feeding (table 2).
Underfeeding did, however, decrease liver trGSH levels in
both TNFa-KO and NGF-tg mice. Furthermore, trGSH
levels in TNFa-KO-uf and NGF-tg-uf mice remained
higher than in their WT-uf counterparts (table 2).
Role of TNFa and NGF in LPS tolerance
Baseline serum brain and liver trGSH was generally higher
in TNFa-KO than in WT mice, whether they received LPS
or not (data not shown). As expected, 90 minutes after LPS
injection TNFa was detected only in the serum of WT mice
but not in TNFa-KO mice (ﬁgure 4A). Compared to WT
control mice (ss), serum TNFa was increased (p < 0.01)
in WT mice receiving LPS for the ﬁrst time (sl,
165 ± 11 pg/ml versus ss, 25 ± 5 pg/ml). In contrast, LPS
did not increase serum TNFa in LPS-pretreated mice (ll).
Serum NGF was signiﬁcantly higher (p < 0.001) in
TNFa-KO control mice (ss, 128 ± 9 pg/ml) than in WT
control mice (ss, 62 ± 5 pg/ml) (ﬁgure 4B). LPS decreased
serum NGF in both WT (sl) and TNFa-KO (sl) mice to
23 ± 4 pg/ml and 43 ± 3 pg/ml, but NGF levels remained
higher (p < 0.01) in TNFa-KO mice. LPS-pretreated mice
(ls) of both genotypes had higher serum NGF levels than
saline-pretreated control mice (ss). Also, in LPS-
pretreated, saline-injected (ls) TNFa-KO mice, serum
NGF levels (239 ± 15 pg/ml) were higher (p < 0.001) than
Table 1
Time lines for treatment and food intake measurements in WT and TNFaKO mice
10 11  12 am 6 pm 12 pm 12 am
LPS or saline
injection
Lights out
Lights on
Food intake measurements at 24 hr after LPS
LPS injection
groups
Day 1 Day 4
ss
sl
ls
ll
saline
saline
LPS
LPS
saline
LPS
saline
LPS
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in WT mice (117 ± 10 pg/ml) (ﬁgure 4B). Serum NGF
levels were still higher in twice LPS-injected mice of both
genotypes than in twice saline-injected control mice.
DISCUSSION
LPS has been shown to induce changes in GSH (1), and
GSH may modify the severity of the LPS response [6].
Conﬁrming and extending these ﬁndings, we have previ-
ously shown that hyposensitivity of LPS-pretreated mice
to LPS anorexia is associated with an increase in GSH
tissue levels [22], and here we again observed a negative
correlation between liver trGSH and the anorexic effect of
LPS. Yet, while these data suggest that trGSH plays a role
in LPS anorexia, little is known about the control of GSH
by cytokines, i.e., by the major endogenous mediators of
LPS anorexia, and in particular about the mechanisms of
tissue GSH regulation by cytokines in vivo. The results
presented here begin to examine these mechanisms. The
higher basal trGSH and NGF levels observed in brains and
livers of TNFa-KO compared to WT mice, and the fact that
***
a
***
***
***
c
***
***
***
c
***
***
***
***
***
***
***
***
***
BA
DC
E F
0
5
10
15
20
25
Cont 15 90 240
Li
v
er
 G
lu
ta
th
io
ne
 (μ
mo
les
/g) WT TNF KO
0
20
40
60
80
Cont 15 90 240
B
ra
in
 T
N
F 
(pg
/m
L)
0
250
500
750
1000
Cont 15 90 240
Li
v
er
  
TN
F 
(pg
/m
L)
0.4
0.9
1.4
1.9
2.4
Cont 15 90 240
B
ra
in
 G
lu
ta
th
io
ne
 (μ
mo
les
/g) WT TNF KO
***
***
0
50
100
150
Cont 15 90 240
B
ra
in
 N
G
F 
(pg
/m
L)
0
2000
4000
Cont 15 90 240
Li
v
er
 N
G
F 
 (p
g/m
L)
c
***
***
***
Figure 1
Acute changes in brain and liver total reduced GSH (trGSH), TNFa and NGF levels in response to ip LPS (4 lg / 25 g BW). Fifteen, 90 and
240 minutes after injections mice were sacriﬁced, brain and liver tissues were collected and assayed for trGSH (A, B), TNFa (C, D) and NGF
(E, F) as described in Methods and materials. Note that TNFa-KO mice showed signiﬁcantly higher basal levels of trGSH and NGF than WT
mice. In both WT and TNFa-KO mice, a signiﬁcant decrease in trGSH and NGF in both brain and liver was observed at 15 and 90 minutes after
LPS; n = 4 for all columns, a = p < 0.01; c and *** = p < 0.001; a, c = comparisons between the two genotypes at the same time point;
*** = comparisons between LPS and control treatments within genotypes.
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these differences more or less persisted after LPS admin-
istration, suggest that TNFa somehow decreases trGSH
and NGF. The latter ﬁnding is consistent with other studies
showing that TNFa-KO mice had increased brain NGF
(18). The decrease in GSH and NGF by TNFa may be due
to the fact that TNFa is a major determinant of the level of
oxidative stress in response to LPS, which then draws upon
the existing pool of antioxidants including GSH and NGF.
Other cytokines may also affect GSH however, because
TNFa-KO mice have been shown to have lower serum
IFNc levels than LPS-naïve WT mice in response to LPS
(23). The results show that TNFa deﬁciency does not alter
basal serum growth hormone or leptin levels. This suggests
that growth hormone does not mediate acute changes in the
GSH in response to LPS, but it may still play a role later
[15]. Leptin’s response to LPS appeared to be largely
independent of TNFa because TNFa-KO mice had el-
evated circulating leptin levels at 240 minutes after LPS
injection. In contrast, TNFa appears to be a major stimulus
of leptin secretion in mice with high fat diet-induced
obesity because in this model the increase in circulating
leptin was shown to be much smaller in TNFa-KO mice
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Figure 2
Acute changes in serum growth hormone (GH) (A) and leptin (B) levels in response to ip LPS (4 lg / 25 g BW). Fifteen, 90 and 240 minutes after
injections mice were sacriﬁced, serum was collected and assayed for GH and leptin as described in Methods and materials. Note that TNFa-KO
mice showed no signiﬁcant differences in basal levels of GH and leptin compared to WT mice. Only in WT mice was leptin decreased at 90
minutes after LPS injection (n = 6, *** = p < 0.01). At 240 minutes after LPS injection, leptin was increased in only TNFa-KO mice; ** and
b = p < 0.01; b = comparison between genotypes at the same time point; *** = comparisons between LPS and control treatments within
genotypes.
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Figure 3
Basal total reduced GSH (trGSH) levels (3A), anorexic response to ip LPS (3B), and serum TNFa, NGF and IFNc responses to ip LPS in WT and
NGF-tg mice. Mice were sacriﬁced as described in the Methods and materials section to determine basal trGSH levels in brain, liver and serum
(3A). All tissues of NGF-tg mice showed signiﬁcantly higher trGSH levels than WT mice (n = 6, c = p < 0.001). WT and NGF-tg mice were
injected ip with LPS (4 lg/25 g BW) and food intake was measured every 24 h for three days. LPS reduced food intake in mice of both genotypes,
but NGF-tg mice showed less anorexia than their WT counterparts (3B). Serum TNFa and IFNc were reduced in NGF-tg mice at 240 minutes
after LPS injection compared to WT mice (3C). n = 6, b = p < 0.01, c = p < 0.001; b, c = comparisons between genotypes at the same time point.
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Figure 4
Serum TNFa and NGF response to ip LPS in LPS naïve and LPS pretreated TNFa-KO and WT mice. Serum TNFa was increased after LPS in
naïve WT mice (sl) but not in LPS pretreated WT mice (ls or ll), and no TNFa was detected in TNFa-KO animals at 90 minutes after LPS injection
(4A). Basal serum NGF was signiﬁcantly higher in TNFa-KO mice than in WT mice (p < 0.001). Note that LPS-pretreated TNFa-KO mice (ls)
had higher NGF levels than LPS-pretreated WT mice (ls) and that the second LPS injection decreased NGF in the former but not the latter (4B).
c and *** = p < 0.001; *** = comparison to ss within genotype; c = comparison between genotypes.
Table 2
Effect of underfeeding on brain and liver glutathione
Brain GSH lmol/g of tissue Liver GSH lmol/g of tissue
WT 1.6 ± 0.03 9.3 ± 0.2
WTuf 1.4 ± 0.02 5.8 ± 0.1**
TNFa KO 1.9 ± 0.03 17.1 ± 0.6
TNFa KOuf 2.1 ± 0.02 14.8 ± 0.3**,a
WT 1.1 ± 0.02 7.8 ± 0.2
WTuf 1.2 ± 0.02 4.3 ± 0.2***
NGF-tg 3.0 ± 0.03 15.8 ± 0.2
NGF-tguf 3.2 ± 0.02 13.8 ± 0.1***,a
** or *** are comparison of the underfed group to its respective ad lib control; a is the comparison between the underfed genetically modiﬁed group to its underfed WT group.
** - p < 0.01; a and *** - p < 0.001.
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than in WT mice. [24]. Previous studies have suggested a
role for leptin in GSH regulation [25]. We report here a
similar pattern of changes in serum leptin and liver trGSH
levels in response to LPS. Serum leptin and liver trGSH
levels were decreased at 15 minutes after LPS in WT mice.
Likewise, at 240 minutes after LPS injection there was an
increase in serum leptin and liver trGSH. Whether this
similar reaction pattern in response to LPS reﬂects causal-
ity, and if so, whether leptin inﬂuences hepatic trGSH or
vice versa, remains to be determined. LPS administration
resulted in decreases of trGSH, which occurred in brains
and livers of LPS naïve TNFa-KO and WT mice. Although
TNFa-KO mice had increased basal NGF and trGSH lev-
els, LPS still decreased trGSH in these animals, suggesting
that factors other than TNFa mediated this effect. It is
presently unknown whether the LPS-induced changes in
tissue trGSH were mediated by cytokines other than TNFa
or by other, “non-cytokine” factors. Although trGSH ﬁrst
decreased in response to LPS and then returned to near
basal levels at 240 minutes after LPS injection, trGSH was
reduced in the brains of WT mice at 24 hours after a single
LPS injection. This temporal difference could be due to the
cyclic ﬂuctuations in trGSH [26], to the anorexia itself, or
to the time course of cytokine changes after LPS. Accord-
ing to our ﬁndings, the LPS-induced anorexia per se
cannot explain the trGSH changes at 24 hours after LPS in
our experiments because food restriction to the level of
LPS-injected mice did not lead to the same reduction in
brain trGSH levels, although a reduction in liver trGSH did
occur in food-restricted mice as after LPS injection. In
addition, the reduction in trGSH at 15 and 90 minutes after
LPS injection cannot be explained by changes in food
intake. TNFa-KO mice developed hyposensitivity to LPS
anorexia in response to a single LPS pretreatment, as did
their corresponding WT mice [data not shown, 22]. This
indicates that TNFa is neither necessary for the develop-
ment of hyposensitivity to LPS anorexia nor for the LPS-
induced changes in tissue trGSH [data not shown, 22]. On
the other hand, development of hyposensitivity to LPS
anorexia was accompanied by a blunted TNFa response to
LPS, suggesting that TNFa contributes to LPS anorexia
[8]. Altering antioxidant levels in various animal models
has been shown to alter the release of cytokines. Our data
show that the antioxidant trGSH is handled in different
ways in TNFa-KO and WT mice, in both the acute re-
sponses to LPS in LPS-naïve mice and during hyposensi-
tivity to LPS. We also found a high correlation between
liver trGSH and NGF. This correlation appears to reﬂect a
causal relationship because NGF-tg mice had higher brain
and liver trGSH levels. NGF apparently regulates trGSH
levels [17]. Furthermore, NGF overexpressing NGF-tg
mice naïve to LPS showed less anorexia than their WT
counterparts in response to LPS, i.e., high levels of NGF
protected against LPS anorexia. This effect may, at least in
part, be due to trGSH because liver, plasma and brain
trGSH levels were higher in NGF-tg than in WT mice. As
NGF-tg mice also had lower serum levels of TNFa and
IFNc than WT mice in response to LPS administration, the
different sensitivity to LPS anorexia may also be due to
this different cytokine response. It is of interest to note that
NGF and IFNc apparently have antagonistic effects [27].
IFNc has previously been shown to be an important media-
tor of LPS-induced anorexia, probably more important
than TNFa [23, 28]. Also, IFNc is a major contributor to
LPS-induced oxidative stress [10, 29], which may be re-
sponsible for some of the pathological changes induced by
LPS. Given the role of IFNc in LPS-induced oxidative
stress, the decrease in liver and brain trGSH levels associ-
ated with the increase in serum IFNc presumably reﬂects
the enhanced demand on antioxidant mechanisms after
LPS injection. Nevertheless, IFNc does not appear to be
involved in basal trGSH regulation because it was not
detected in the plasma of LPS naïve mice. It is interesting
that LPS increased trGSH in brain and liver more, and
circulating TNFa and IFNc levels less in NGF-tg mice
than in corresponding WT mice, suggesting that NGF is
involved in the response of all these parameters to LPS.
Consistent with the higher NGF levels in liver and brain,
serum NGF was also always higher in TNFa-KO mice than
in WT mice, under baseline conditions and after LPS
injection. Serum NGF was particularly high at 24 h after
LPS injection, when the animals had almost completely
lost their sensitivity to the anorexic effect of LPS. This
ﬁnding is again consistent with a role of NGF in reducing
the anorexic effect of LPS. In summary, our study suggests
that TNFa regulates trGSH via NGF in a tissue-speciﬁc
manner and that liver trGSH levels are associated with the
degree of LPS-induced anorexia in LPS-naïve mice. Inter-
estingly, we also show that increases in serum NGF levels
occur during the development of LPS tolerance, indicating
that NGF, unlike TNFa, still responds to LPS injection in
LPS-pretreated mice. The generality of this phenomenon,
i.e., whether for instance NGF- or NGF receptor-deﬁcient
mice or mice deﬁcient in IFNc show changes in trGSH
levels and whether these changes control the mices sensi-
tivity to LPS-induced anorexia remains to be examined.
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